Post-Infarction Inflammation and Left Ventricular Remodeling:– A Double-Edged Sword –
スポンサーリンク
概要
- 論文の詳細を見る
After myocardial infarction (MI), inflammatory cells such as neutrophils, followed by monocytes and macrophages, infiltrate and phagocytose the necrotic tissues, as well as secreting a variety of inflammatory cytokines. The vulnerable myocardium, which consists of necrotic tissue and inflammatory cells, is susceptible to wall stress, resulting in infarct expansion. Subacute cardiac rupture is an extreme form of infarct expansion, whereas ventricular aneurysm is its chronic form and a trigger for subsequent left ventricular (LV) remodeling. Although post-infarction inflammation is essential for the healing process, excessive inflammation could play an important role in the development of LV remodeling. Increase in the C-reactive protein level, which reflects myocardial inflammation, is reported to be a useful predictive marker for cardiac rupture, ventricular aneurysm and LV remodeling. In addition, an increase in peripheral monocyte count is associated with a poor outcome after MI, and an animal study has demonstrated that granulocyte/macrophage-colony stimulating factor induction causes excessive macrophage infiltration in the infarcted area and worsening of LV remodeling. Recently, it was also found that dendritic cells play an important role in controlling excessive inflammation caused by monocytes/macrophages. Thus, inflammation that develops after MI is a double-edged sword, and how to control inflammation to suppress pathological remodeling is an important issue to be considered in developing new treatment for heart failure. (Circ J 2013; 77: 580–587)
著者
関連論文
- PE-434 The Beneficial Effect of Angiotensin II Type 1 a Receptor Ablation on Diabetes-induced Cardiomyopathy may be Elicited with the Improvement of Hsp110 Expression(Heart failure, basic-4, The 71st Annual Scientific Meeting of the Japanese Circulation S
- DPE-010 Increased C-reactive Protein Expression Exacerbates Left Ventricular Dysfunction and Remodeling after Myocardial Infarction in Mice(DPE02,Heart Failure, Basic (M),Digital Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese
- PE-221 Intravenous Administration of Immunoglobulin Attenuates Myocardial Reperfusion Injury and Improves Left Ventricular Remodeling(Myocardial ischemia/reperfusion, basic/clinical(03)(IHD),Poster Session(English),The 72nd Annual Scientific Meeting of th
- PJ-471 Epicardial Fat Volume Assessed by 64-Slice MDCT is Related to the Presence of Metabolic Syndrome and Ischemic Heart Disease(CT/DSA-10, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- FRS-027 Presence of Autoantibody against β-adrenergic Receptors is Associated with Amelioration of Cardiac Function during β-blocker Therapy for Congestive Heart Failure(Clinical Heart Failure-Pathophysiology and Treatment, The 71st Annual Scientific Meet
- PE-386 Blockade of Angiotensinll Type 1a Receptor Ameliorates Cardiac Dysfunction Induced by Diabetes Mellitus(Heart failure, basic-4 (M) PE65,Poster Session (English),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
- OE-015 Peripheral Blood Level of Matrix Metalloprotease-9 is Elevated in Patients with Acute Aortic Dissection(Emergency care-1 (H) OE3,Oral Presentation (English),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
- OJ-145 Stroke Complicating PCI(Coronary revascularization, PCI-07, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- -P257- Chamber-specific Abnormalities in Sympathetic Signal Transduction Pathway in Acute Left Ventricular Failure(PROCEEDINGS OF THE 59th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY)
- Tumor Necrosis Factor-α Converting Enzyme Inactivation Ameliorates High-Fat Diet-Induced Insulin Resistance and Altered Energy Homeostasis
- Titration of β-Blockers for Patients With Heart Failure
- Post-Infarction Inflammation and Left Ventricular Remodeling:– A Double-Edged Sword –
- Guidelines for Treatment of Acute Heart Failure (JCS 2011) : Digest Version